Case File
efta-efta00644093DOJ Data Set 9OtherFrom: Hosain Rahman
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00644093
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Hosain Rahman
To: Jeffrey Epstein <[email protected]>
Subject: Re: Mort: Exchange Offer
Date: Thu, 19 Feb 2015 18:53:05 +0000
ok good thanks
On Feb 19, 2015, at 10:34 AM, jeffrey E. <[email protected]> wrote:
my guys are supposed to have a call with your poeple today thanks
On Thu, Feb 19, 2015 at 11:49 AM, Hosain Rahman <
> wrote:
Hi - see below the offer is to convert your common into higher priced preferred at a 3.5X ratio. Gives you a
really nice guaranteed returned on the old shares.
We are closing this out soon, so wanted to make sure you had the opportunity to participate. Let me know if
you have any questions.
Begin forwarded message:
From: Hosain Rahman
Date: February 16, 2015 at 2:00:38 PM MST
To: Jeffrey Epstein <[email protected]>
Subject: Fwd: Mort: Exchange Offer
FYI
Begin forwarded message:
From: Anna Podkovyrova <
Date: February 16, 2015 at 1:50:37 PM MST
To: "Hosain Rahman "
, Andrew Lindsay
Cc: Will Hawthorne
Subject: Mort: Exchange Offer
Andrew,
Wanted to clearly lay out the exchange offer as it pertains to Mon.
Exchange offer
EFTA00644093
For each new share of Series 6 preferred purchased, Mort gets to take a share of common stock and convert it to 3.5
shares of Series 6 preferred.
As you know Series 6 has a lx liquidation preference and is senior to all other rounds, so this offer allows the common to
move up in the stack to be the most senior equity and gives them a liquidation price of $39.44 a share ($11.26 x 3.5).
It is an amazing offer for shareholders that own common.
See below — if they invest $14mm now they end up with $64mm (5.7mm shares x $11.26) of Series 6 Liquidation
Preference:
cimage003.png>
Please visit http://www.codeadvisors.corrildisclaimer.html for important disclaimer information regarding
this communication.
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00644094
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://www.codeadvisors.corrildisclaimer.htmlRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.